Loading…
Institutional investors involved in the transaction.
Bluejay Diagnostics, Inc. (Nasdaq: BJDX) has entered into a warrant inducement transaction with institutional investors on April 7, 2025. The transaction involves the issuance of approximately $3.7 million in gross proceeds.
The company will issue 1,085,106 shares of common stock at a price of $3.42 per share. The float stands at 1,270,000 shares, with 1,814,100 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.